![Patricia Carlos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Patricia Carlos worked at Jasper Therapeutics, Inc. as Senior Vice President-Regulatory Affairs & Quality.
From 2019 to 2022, Ms. Carlos was Senior Vice President-Regulatory & Quality at Arcus Biosciences, Inc. From 2022 to 2023, Ms. Carlos was Chief Regulatory, Quality & Safety Officer at Agenus, Inc. Ms. Carlos completed undergraduate education at Memorial University of Newfoundland.
Eerdere bekende functies van Patricia Carlos
| Bedrijven | Functie | Einde |
|---|---|---|
| AGENUS INC. | Algemeen Adviseur | 01-05-2023 |
| ARCUS BIOSCIENCES, INC. | Algemeen Adviseur | 01-09-2022 |
| JASPER THERAPEUTICS, INC. | Algemeen Adviseur | - |
Opleiding van Patricia Carlos
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Memorial University of Newfoundland
 Memorial University of Newfoundland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
